Stockreport

Enanta: Multiple Shots On Goal For RSV Makes This A Must Watch [Seeking Alpha]

Enanta Pharmaceuticals, Inc.  (ENTA) 
Last enanta pharmaceuticals, inc. earnings: 2/6 04:00 pm Check Earnings Report
US:NASDAQ Investor Relations: ir.enanta.com/investor-overview
PDF Data to be released from phase 2a challenge study, using L-protein inhibitor EDP-323, expected in Q3 of 2024. It is expected that the global Respiratory Syncytial Vir [Read more]